Innovating to revolutionize women’s health
Our core ethos is to expand freedom for women. We are pushing the limits of what’s possible by building products centered on self-determination, increasing overall quality of life for women everywhere.
Our first product under development
A novel approach to birth control, aiming to reinforce the natural cervical mucus barrier to provide effective birth control on demand without any hormones.
EXPLORING THE POTENTIAL FOR A MUCUS REINFORCING CONTRACEPTIVE
Introduction
Cirqle’s technology is being evaluated for its potential to make cervical mucus temporarily impenetrable to sperm. It is believed that a barrier may be established by a molecule that interacts with cervical mucus and reinforces the natural barrier, preventing sperm cells from breaching the cervical mucus barrier. The technology is designed to provide a localized option, interacting with the superficial mucus layer directly.
The technology is currently in pre-clinical development.
WE MUST DO BETTER
What drives us?
1960 was a defining moment in history. The introduction of oral birth control was a turning point for women’s reproductive rights. Access to “the pill” afforded women more bodily autonomy than ever before, offered greater financial freedom and acted as a foundation for historic achievements in gender equity.
Unfortunately, this momentum of innovation in contraception was not maintained. More than 60 years later, a new mechanism of action in contraception has not been developed, despite a significant share of women experiencing physical and mental side-effects from using hormonal contraception.
Our goal is to uphold the radical ideals that fueled the initial birth control movement and provide a new contraceptive option desired by millions of women.
Do you want to join our journey of harnessing technology to empower women?
Career opportunities
“In the past, new biomedical discoveries have only very late — if ever — applied to women’s health. Our vision is to harness new discoveries to create long-overdue breakthrough treatments for women.”
— Frederik Petursson Madsen, co-founder